Hundreds of women with hard-to-treat ovarian cancer could benefit from a new, life-extending drug on the NHS from today – the first new addition to NHS treatment in over 20 years. The new targeted therapy – mirvetuximab soravtansine – will be offered to patients living with ovarian cancer whose disease has stopped responding to standard […]
Your cart (items: 0)
Subtotal
$0.00
Shipping and discounts calculated at checkout.
Your cart is currently empty!